Eribuline: Nieuw oncolyticum voor de behandeling van gemetastaseerde borstkanker

Translated title of the contribution: Eribulin: New oncolytic agent for the treatment of metastatic breast cancer

M. M.L. Van Keep, A. D.R. Huitema*, J. H.M. Schellens, J. H. Beijnen

*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

Fingerprint

Dive into the research topics of 'Eribulin: New oncolytic agent for the treatment of metastatic breast cancer'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science